Leqvio

LEQVIO (inclisiran) is an injectable prescription medicine used along with diet and other lipid-lowering medicines in adults who need additional lowering of “bad” cholesterol (LDL-C) and have known cardiovascular disease and/or heterozygous familial hypercholesterolemia (HeFH), an inherited condition that causes high levels of LDL-C. It is not known if LEQVIO can decrease problems related to high cholesterol, such as heart attacks or stroke.

Infusion Experience

Since LEQVIO is an injection given in-office by a health care provider, there’s no self-injection.

LEQVIO is dosed differently than other injectable LDL-C–lowering therapies.

  • 2 doses per year, together with a statin.
  • Initial dose, again at 3 months, then once every 6 months at your doctor’s office

Possible Side Effects

The most common side effects of LEQVIO were: injection site reaction (including pain, redness, and rash), joint pain, urinary tract infection, diarrhea, chest cold, pain in legs or arms and shortness of breath.

These are not all the possible side effects of LEQVIO. Ask your health care provider for medical advice about side effects.